BIOTIME has recieved FDA and EUA approval for thei

BIOTIME has recieved FDA and EUA approval for their rapid coalitative test ( results within 20 minutes) .Sounds very familiar to what Minns described during the trial.


Login
Infectious disease
SARS-CoV-2 IgG/IgM


Online consultation
Product DescriptionSystem ParameterPerformance Index


The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit is intended to detect SARS-CoV-2 IGg and IgM antibody in human serum, plasma or whole blood by colloidal gold method.


5.png



Immunoglobulin M (IgM), which is found mainly in the blood and lymph fluid, is the first antibody to appear in the response to initial exposure to a new infection. IgM is with high specificity and high sensitivity to 2019-Novel Coronavirus(SARS-CoV-2), which has significant value in early detecting 2019-Novel Cornavirus(SARS-CoV-2). Immunoglobulin G (IgG), the most abundant type of antibody, is found in blood and protects against viral and bacterial infections. IgG appears later than IgM when infected with SARS-CoV-2, but it can persist in the blood for several months, so positive IgG may indicate patients were ever infected with virus.

1582541703432984.png

Symptoms of people with SARS-CoV-2

Illness can range from people with mild symptoms to people being severely ill and dying. Symptoms can include:

●Fever

●Cough

●Shortness of breath



Test Procedures

① Mark the sample number on cartridge

② Take serum, plasma or whole blood 10uL and load it into sample well of cartridge

③ Drop 2 drops of buffer

④ Wait 15 minutes


Interpretation of Test Result

1582541571708064.jpg



© 2016 Xiamen Biotime Biotechnology Co., Ltd. all rights reserved

互联网药品信息服务资格证书[(闽)-非经营性-2018-0037] [ (闽) -ICP备13013125号 ]